---
layout: archive
title: "CV"
permalink: /cv/
author_profile: true
redirect_from:
  - /resume
---

{% include base_path %}

Education
======
* B.A. in Philosophy, University of Groningen, 2013
* B.Sc. in Medicine and Global Health, University of Groningen, 2013
* Medical School, University of Groningen, 2017
* PhD in Infectious Diseases, University of Groningen, 2018

Work experience
======
More to come

Selected Publications
======

1. Groschel MI et al., The phylogenetic landscape and hospital transmission of the emerging pathogen  Stenotrophomonas maltophilia, Nature Communications 2020; 10.1038/s41467-020-15123-0 

1. Groschel MI, Seddon JA, Prabowo SA, Migliori GB, Graham SM, van den Boom M, Dara M. European Guidance on drug-resistant tuberculosis in children and adolescents. Lancet Child & Adolesc Health 2019;10.1016/S2352-4642(19)30332-3.

1. Lead writing and coordination of WHO guidance: Multidrug-resistant tuberculosis in children and adolescents in the WHO European Region, Expert Opinion. Copenhagen: WHO Regional Office for Europe; 2019. 

1. Groschel MI, Walker T, van der Werf TS, Lange C, Niemann S, Merker M. Pathogen-based precision medicine for multidrug-resistant tuberculosis. PloS Pathog 2018;14(10):e1007297

1. Groschel MI et al., Recombinant BCG expressing ESX-1 of Mycobacterium marinum combines low virulence with cytosolic immune signalling and improved tuberculosis protection. 
Cell Reports 2017;18:2752-2765

1. Groschel MI, Sayes F, Roxane S, Majlessi L, Brosch R. ESX secretion systems: mycobacterial evolution to counter host immunity. Nat Rev Microbiol 2016 Nov;14(11):677-691

1. Lai FY*, Groschel MI*, van den Hende L, Diercks, GF, Rutgers A, van der Werf TS. Prolonged pyrexia and subtle skin lesions: polyarteritis nodosa. Lancet 2016;5(387):1025-6.

1. Groschel MI, Prabowo SA, Cardona PJ, Stanford JL, van der Werf TS. Therapeutic Vaccines for Tuberculosis – a Systematic Review. Vaccine 2014;32(26):3162-8.

  
Talks
======
1. Oral Presentation (12 min). European Conference on Clinical Microbiology and Infectious Diseases (ECCMID)
  Paris, France, 18-22 April 2020, cancelled due to COVID-19

1. Oral Presentation (25 min). 3rd Regional Workshop on Childhood Tuberculosis
  Copenhagen, Denmark, 29 - 30 January, 2020

1. Oral Presentation (12 min). European Society for Pediatric Infectious Diseases (ESPID)
  Malmö, Schweden, 28 Mai – 2 Juni, 2018

1. Oral Presentation (15 min). 5th Global Forum on TB Vaccines
New Delhi, India, 20 – 23 February 2018

1. Poster Cell-Weizmann Institute of Science Symposium: Next Gen Immunology 
Rehovot, Israael, 11 -14 February 2018 

1. Oral Presentation (12 min). European Conference on Clinical Microbiology and Infectious Diseases (ECCMID)
Vienna, Austria, 22 – 25 April 2017
  
1. Invited Presentation (45 min). VIdo Intervac, University of Saskatoon
Saskatchewan, Canada, 24th July 2017
    
1. Poster. Development of Tissue- and Pathogen-specific Cellular Innate Immunity 
Freiburg, Germany, 27 – 29 September 2017

1. Poster. Keystone Conference on Nucleic Acid Sensing Pathways: Innate Immunity, Immunobiology and Therapeutics, Dresden, Germany, 9 – 12 May 2016

1. Invited Presentation (30 min). Departmental Seminar, Peter Doherty Institute, 
Melbourne, Australia, 13th October 2016

  
Teaching
======
  <ul>{% for post in site.teaching %}
    {% include archive-single-cv.html %}
  {% endfor %}</ul>
  
Awards
======
1. 2019  Annual PhD Price, Research Center Borstel and Municipality of Bad Segeberg
1. 2018  Annual Research Price, Hippocrates Foundation, Leiden, Netherlands 
1. 2017  Best Translational Poster, Innate Immunity Symposium Freiburg, Germany
1. 2014  Best M.sc. Thesis of the year, Alumni Association of the Faculty of Medicine, University of Groningen, Groningen, The Netherlands

